CCB
NVO

Cutter & Co Brokerage’s Novo Nordisk NVO Stock Holding History

Cutter & Co Brokerage’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-282,972
Closed -$19.6M – 112
2025
Q1 		$19.6M Sell
282,972
-7,129
-2% -$589K 4.65% 3
2024
Q4 		$25M Buy
290,101
+8,306
+3% +$898K 6.09% 2
2024
Q3 		$33.6M Sell
281,795
-2,383
-0.8% -$318K 7.59% 2
2024
Q2 		$40.6M Sell
284,178
-3,108
-1% -$412K 9.83% 2
2024
Q1 		$36.9M Sell
287,286
-3,842
-1% -$457K 9.06% 2
2023
Q4 		$30.1M Sell
291,128
-788
-0.3% -$77.9K 8.36% 2
2023
Q3 		$26.5M Buy
291,916
+9,838
+3% +$867K 7.76% 2
2023
Q2 		$22.8M Buy
282,078
+9,998
+4% +$817K 6.73% 2
2023
Q1 		$21.6M Buy
272,080
+1,960
+0.7% +$139K 6.75% 2
2022
Q4 		$18.3M Buy
270,120
+177,952
+193% +$10.4M 6.18% 2
2022
Q3 		$4.59M Sell
92,168
-68
-0.1% -$3.64K 1.71% 9
2022
Q2 		$5.14M Buy
92,236
+12
+0% +$666 1.75% 9
2022
Q1 		$5.12M Sell
92,224
-278
-0.3% -$14.3K 1.52% 10
2021
Q4 		$5.18M Buy
92,502
+664
+0.7% +$36K 1.42% 13
2021
Q3 		$4.41M Sell
91,838
-1,594
-2% -$77.1K 1.05% 18
2021
Q2 		$3.91M Sell
93,432
-202
-0.2% -$7.83K 0.9% 28
2021
Q1 		$3.16M Sell
93,634
-710
-0.8% -$25.3K 0.77% 41
2020
Q4 		$3.29M Sell
94,344
-3,708
-4% -$128K 0.87% 34
2020
Q3 		$3.4M Sell
98,052
-2,494
-2% -$83.1K 1.01% 22
2020
Q2 		$3.29M Sell
100,546
-12,340
-11% -$394K 1.07% 25
2020
Q1 		$3.4M Sell
112,886
-19,810
-15% -$590K 1.28% 20
2019
Q4 		$3.84M Sell
132,696
-16,946
-11% -$469K 1.35% 14
2019
Q3 		$3.87M Sell
149,642
-33,600
-18% -$850K 1.24% 12
2019
Q2 		$4.68M Sell
183,242
-7,804
-4% -$193K 1.48% 9
2019
Q1 		$5M Sell
191,046
-10,990
-5% -$270K 1.42% 11
2018
Q4 		$4.65M Sell
202,036
-102,620
-34% -$2.28M 1.77% 8
2018
Q3 		$7.18M Sell
304,656
-24,918
-8% -$608K 2.45% 4
2018
Q2 		$7.6M Sell
329,574
-16,024
-5% -$381K 2.93% 3
2018
Q1 		$8.51M Buy
345,598
+7,256
+2% +$191K 3.36% 2
2017
Q4 		$9.08M Sell
338,342
-15,740
-4% -$400K 3.73% 2
2017
Q3 		$8.53M Sell
354,082
-12,578
-3% -$284K 3.38% 2
2017
Q2 		$7.86M Sell
366,660
-3,828
-1% -$77.2K 3.09% 2
2017
Q1 		$6.35M Buy
370,488
+13,380
+4% +$233K 2.62% 3
2016
Q4 		$6.4M Buy
357,108
+76,572
+27% +$1.39M 2.65% 3
2016
Q3 		$5.83M Buy
280,536
+75,310
+37% +$1.87M 2.54% 5
2016
Q2 		$5.52M Buy
205,226
+5,200
+3% +$143K 2.36% 9
2016
Q1 		$5.42M Buy
200,026
+31,570
+19% +$846K 2.5% 6
2015
Q4 		$4.89M Buy
168,456
+70,070
+71% +$1.94M 2.29% 7
2015
Q3 		$2.67M Sell
98,386
-900
-0.9% -$25.5K 1.31% 20
2015
Q2 		$2.72M Sell
99,286
-27,010
-21% -$759K 1.08% 25
2015
Q1 		$3.37M Buy
126,296
+136
+0.1% +$3.13K 1.37% 15
2014
Q4 		$2.67M Buy
126,160
+190
+0.2% +$4.24K 1.02% 30
2014
Q3 		$3M Sell
125,970
-2,600
-2% -$59.8K 1.15% 25
2014
Q2 		$2.97M Buy
128,570
+1,138
+0.9% +$25.1K 1.09% 26
2014
Q1 		$2.91M Sell
127,432
-1,598
-1% -$34K 1.15% 24
2013
Q4 		$2.38M Buy
129,030
+2,920
+2% +$50.9K 1.11% 33
2013
Q3 		$2.13M Buy
126,110
+1,430
+1% +$24.1K 0.95% 36
2013
Q2 		$1.93M Buy
+124,680
New +$2.08M 0.92% 38

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cutter & Co Brokerage's NVO Position: Q2 2025 in Review

Cutter & Co Brokerage sold out of Novo Nordisk (NVO) in Q2 2025, closing a stake of 282,972 shares — an estimated $19.6M sold.

Cutter & Co Brokerage first reported a position in NVO in Q2 2013 and held it in 48 quarters. The position peaked at $40.6M in Q2 2024. 1,482 funds tracked by Wall St. Rank hold NVO as of Q2 2025.

  • Cutter & Co Brokerage reported no remaining Novo Nordisk position as of Q2 2025 after selling out during the quarter.
  • Cutter & Co Brokerage sold 282,972 Novo Nordisk shares in Q2 2025, an estimated $19.6M.
  • Cutter & Co Brokerage first reported a position in Novo Nordisk in Q2 2013 and held it in 48 quarters.
  • Cutter & Co Brokerage's Novo Nordisk position peaked at $40.6M in Q2 2024.
  • 1,482 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2025.

Based on Cutter & Co Brokerage's 13F filing for Q2 2025.